Close Menu

NEW YORK – Becton Dickinson reported on Thursday morning that its fiscal second quarter revenues increased just over 1 percent year over year.

On a currency-neutral basis, Q2 revenues increased more than 2 percent, BD said.

For the three months ended March 31, BD posted revenues of $4.25 billion compared to $4.20 billion in the year-ago quarter and below the average analyst estimate of $4.16 billion.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

NPR reports the US Food and Drug Administration has approved a treatment for a genetic disorder that causes rapid aging.

Late-stage testing indicates the AstraZeneca and Oxford University SARS-CoV-2 vaccine can have up to 90 percent efficacy, the Associated Press reports.

ScienceInsider reports Nature Communications is reviewing a paper on mentorship following social media criticism arguing it is sexist.

In PLOS this week: method to account for sequencing errors in phylogenies, study of influenza A in Switzerland, and more.

Sponsored by
Mission Bio

Recent work by many investigators has discovered that over the course of aging, hematopoietic stem cells (HSCs) commonly undergo clonal expansion.